Ocular disease program (Pieris Pharmaceuticals/Genentech)

N/A

Report date: 2025/01/26 15:52:51
NME

Base Information

Drug NameOcular disease program (Pieris Pharmaceuticals/Genentech)
Drug Alias NameOcular disease program (Pieris Pharmaceuticals/Genentech)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPieris Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesPieris Pharmaceuticals IncGenentech Inc
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A